Healthcare Policies: Positive trial results could prompt discussions among policymakers and health authorities about the inclusion of semaglutide in insurance coverage or national healthcare programs
It suppresses hunger hormones, helping reduce food intake and overall daily calorie consumption
The STEP 1 trial showed average weight loss of 14.9% over 68 weeks
Benefits of semaglutide in glycemic control, weight reduction, and cardiovascular risk mitigation remain well established
Blood glucose monitoring frequency should be individualised based on overall diabetes regimen and stability
In a microwell ELISA plate pre-coated with anti-mouse glutathione peroxidase (GSH-Px) antibody (solid phase antibody), add mouse glutathione peroxidase (GSH-Px) calibrator and the sample to be tested, then add biotin-labeled antibody, incubate and fully wash, then add HRP-coupled avidin, incubate and fully wash to remove unbound components, and form a sandwich complex of solid phase antibody-antigen-biotin-labeled antibody-avidin enzyme on the solid surface of the microwell plate
